Diagnosis and Treatment Timeline: Different Phases of Ph+ ALL Management

The panel provides an overview of the various Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) treatment phases, highlighting the important discussion around inpatient versus outpatient care.

EP: 1.Overview of Characteristics Unique to Ph+ ALL

EP: 2.Timely Detection: Incidence and Prevalence of Ph+ ALL

EP: 3.Supporting Ph+ ALL Patient: Emotional Challenges and Quality of Life

EP: 4.Screening and Diagnosing of Ph+ ALL in Adults

Now Viewing

EP: 5.Diagnosis and Treatment Timeline: Different Phases of Ph+ ALL Management

EP: 6.Current Front-Line Targeted Treatments in Ph+ ALL

EP: 7.Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients

EP: 8.PhALLCON Trial: Efficacy and Safety of Ponatinib in Ph+ ALL Patients

EP: 9.Value-Based Care Models Optimizing Ph+ ALL Patient Care

EP: 10.Unmet Needs in Screening, Diagnosis, and Management of Ph+ ALL

EP: 11.Disparities in Access to Care for Ph+ ALL patients

EP: 12.The Future of Ph+ ALL Treatments

EP: 13.Concluding Thoughts on Ph+ ALL Treatment

Related Videos

Related Content

Advertisement

Published: February 25th 2025 | Updated: February 25th 2025

Dry Eye Symptom Frequency, Severity Reduced When Using Perfluorohexyloctane

Julia Bonavitacola

Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 24th 2025

Similar Chronic Condition Rates in MA, FFS Beneficiaries Raise Concerns About Overpayments to MA Plans

Brooke McCormick

These findings support the claim that Medicare Advantage (MA) payments may be driven more by diagnosis and coding practices rather than differences in disease burden between MA and fee-for-service (FFS) Medicare beneficiaries.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 21st 2025

AChR-Ab Titers Associated With Myasthenia Gravis Severity

Rose McNulty

Anti-acetylcholine receptor antibody (AChR-Ab) titers and the AChR-Ab rates of change correlated with myasthenia gravis disease severity scores in a recent study.

February 21st 2025

Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury

John K. Yue, MD Nishanth Krishnan, BS Christopher Toretsky, MPH Renee Y. Hsia, MD, MSc Geoffrey T. Manley, MD, PhD W. John Boscardin, PhD Anil N. Makam, MD, MAS Anthony M. DiGiorgio, DO, MHA

Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.

Related Content

Advertisement

Published: February 25th 2025 | Updated: February 25th 2025

Dry Eye Symptom Frequency, Severity Reduced When Using Perfluorohexyloctane

Julia Bonavitacola

Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 24th 2025

Similar Chronic Condition Rates in MA, FFS Beneficiaries Raise Concerns About Overpayments to MA Plans

Brooke McCormick

These findings support the claim that Medicare Advantage (MA) payments may be driven more by diagnosis and coding practices rather than differences in disease burden between MA and fee-for-service (FFS) Medicare beneficiaries.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 21st 2025

AChR-Ab Titers Associated With Myasthenia Gravis Severity

Rose McNulty

Anti-acetylcholine receptor antibody (AChR-Ab) titers and the AChR-Ab rates of change correlated with myasthenia gravis disease severity scores in a recent study.

February 21st 2025

Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury

John K. Yue, MD Nishanth Krishnan, BS Christopher Toretsky, MPH Renee Y. Hsia, MD, MSc Geoffrey T. Manley, MD, PhD W. John Boscardin, PhD Anil N. Makam, MD, MAS Anthony M. DiGiorgio, DO, MHA

Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.